I now have all the information needed for a comprehensive 10-mark answer. Let me compile it.
Conscious Sedation: Indications, Drugs (with Doses) and Post-Procedure Discharge Criteria
Definition
Conscious sedation (also called moderate sedation) is a drug-induced state in which the patient has purposeful responses to verbal or tactile stimulation, maintains a patent airway without intervention, has adequate spontaneous ventilation, and retains cardiovascular function. It is the term used by non-anesthesiologists for what anesthesiologists call Monitored Anesthesia Care (MAC).
Indications
Conscious sedation is used to allow patients to tolerate uncomfortable or anxiety-provoking procedures while remaining cooperative and maintaining protective reflexes:
| Category | Examples |
|---|
| Endoscopic procedures | Upper GI endoscopy, colonoscopy, ERCP, bronchoscopy |
| Minor surgical procedures | Incision and drainage, wound debridement, joint reduction |
| Interventional radiology | Percutaneous transhepatic cholangiography, vascular interventions |
| Cardiac procedures | Cardioversion, cardiac catheterization, pacemaker insertion |
| Emergency procedures | Fracture reduction, foreign body removal, lumbar puncture |
| Dental / oral surgery | Complex extractions, implant procedures |
| Diagnostic imaging | MRI/CT in anxious or pediatric patients |
| Burn care | Dressing changes, debridement |
| Oncology | Bone marrow biopsy, intrathecal chemotherapy |
Drugs Used in Conscious Sedation
The standard regimen combines an opioid analgesic (for pain) with a benzodiazepine anxiolytic (for sedation/amnesia), with agents like ketamine and dexmedetomidine as nonopioid adjuncts.
1. Midazolam (Benzodiazepine)
Mechanism: GABA-A receptor positive allosteric modulator - produces anxiolysis, amnesia, and sedation. Reversible with flumazenil (0.2 mg IV, repeat q1 min, max 1 mg).
| Route | Dose |
|---|
| Induction / sedation (IV) | 0.05 mg/kg IV (titrate slowly); typical adult: 1-2.5 mg IV |
| Sedation (IM) | 0.1-0.15 mg/kg IM |
| Premedication (PO) | 0.5 mg/kg PO (max 20 mg) |
| Maintenance | Repeat 0.5-1 mg IV boluses titrated to effect; no fixed infusion for procedural sedation |
Onset: 2-3 min IV; Duration: 30-60 min. The IV dose in elderly patients should be halved due to increased sensitivity.
2. Ketamine (Dissociative Anaesthetic)
Mechanism: NMDA receptor antagonist - produces dissociative analgesia, amnesia, and sedation while preserving airway reflexes and spontaneous breathing - a unique advantage.
| Route | Dose |
|---|
| Induction (IV) | 1-2 mg/kg IV |
| Induction (IM) | 6-10 mg/kg IM |
| Sedation / procedural (IV) | 0.5-1 mg/kg IV (Yamada's: initial dose 0.5 mg/kg, titrated to desired effect; duration 10-15 min) |
| Maintenance infusion | 25-75 mcg/kg/min IV infusion |
| Premedication (PO/PR) | 6-10 mg/kg PO; 6-10 mg/kg PR |
Key advantages for conscious sedation: Maintains airway protective reflexes, provides analgesia + amnesia simultaneously, useful in haemodynamically unstable patients and for painful procedures (e.g., fracture reduction, wound debridement).
Adjunct: Co-administer midazolam (1-2 mg IV) to reduce emergence reactions (hallucinations, dysphoria). Avoid in patients with raised ICP, psychosis, or uncontrolled hypertension.
3. Pentazocine (Opioid Agonist-Antagonist)
Mechanism: Mixed kappa-agonist / partial mu-agonist opioid - produces analgesia, sedation, and respiratory depression. Exhibits a ceiling effect for analgesia and can precipitate withdrawal in opioid-dependent patients. Classified as a Schedule IV controlled drug.
| Route | Dose |
|---|
| IV | 30 mg IV every 3-4 hours (max 360 mg/day) |
| IM/SC | 30-60 mg IM/SC every 3-4 hours |
| PO | 50 mg PO (equivalent to 60 mg oral codeine for analgesia) |
| For sedation/analgesia | 30 mg IV slow push; may combine with promethazine (25 mg IV) |
Notes: Less commonly used as a primary sedation agent today due to dysphoric side effects (anxiety, hallucinations at higher doses), cardiovascular stimulation (raises BP and HR - unlike morphine), and the availability of superior alternatives. Not reversible by naloxone fully (partial antagonist component). Avoid in acute MI where it may increase cardiac work.
4. Dexmedetomidine (Alpha-2 Agonist)
Mechanism: Highly selective alpha-2 adrenoceptor agonist - produces sedation, anxiolysis, and analgesia with no respiratory depression at clinical doses (unique among sedatives). Patients remain arousable and cooperative ("cooperative sedation"). No reversal agent available.
| Route | Dose |
|---|
| Loading dose (IV) | 0.5-1 mcg/kg infused over 10-15 minutes |
| Maintenance infusion | 0.2-0.7 mcg/kg/hour (titrate to effect; range up to 1.5 mcg/kg/hr) |
| FDA-approved procedural sedation dose | 1 mcg/kg loading over 10 min, then 0.6 mcg/kg/hr maintenance |
Key advantages: Ideal for awake procedures requiring patient cooperation (awake fibreoptic intubation, awake craniotomy, endoscopy). Minimal respiratory depression allows supplemental oxygen but not typically mandatory. Cautions: Bradycardia and hypotension (especially with loading dose); avoid or reduce loading dose in elderly/haemodynamically compromised.
5. Other Standard Agents (for completeness in 10-mark answer)
- Fentanyl (opioid analgesic): 1-2 mcg/kg IV for analgesia; 25-50 mcg IV titrated boluses for procedural sedation. Reversible with naloxone.
- Propofol (induction agent used off-label): 0.5 mg/kg IV induction; maintenance 25-75 mcg/kg/min infusion. High risk of progression to deep sedation; should be administered by trained anesthesia provider.
Post-Operative / Post-Procedure Discharge Criteria for Conscious Sedation
Two validated scoring systems are in widespread use. A score ≥9/10 on either scale is required for discharge.
Modified Aldrete Score
| Parameter | Score 2 | Score 1 | Score 0 |
|---|
| Respiration | Able to deep breathe and cough | Dyspnoea / shallow breathing | Apnoea |
| SpO2 | >92% on room air | Needs O2 to maintain >90% | <90% despite O2 |
| Consciousness | Fully awake | Arousable on calling | Not responding |
| Circulation | BP ±20 mmHg of preop | BP ±20-50 mmHg of preop | BP >50 mmHg deviation |
| Activity | Moves 4 extremities | Moves 2 extremities | Unable to move |
Discharge when score ≥9.
Post-Anaesthetic Discharge Scoring System (PADSS)
| Parameter | Score 2 | Score 1 | Score 0 |
|---|
| Vital signs | Within 20% of preop baseline | Within 20-40% of baseline | >40% deviation |
| Activity | Steady gait, no dizziness | Requires assistance | Unable to ambulate |
| Nausea/vomiting | Minimal / treated with oral meds | Moderate / needs parenteral Rx | Severe despite Rx |
| Pain | Controlled with oral analgesics | Not controlled | - |
| Surgical bleeding | Minimal / no dressing change | Moderate / up to 2 changes | Severe / >3 changes |
Discharge when score ≥9.
Clinical Discharge Criteria (Brigham & Women's / General Consensus)
Beyond scoring systems, the following must be satisfied before discharge:
- Alert and oriented to time and place
- Stable vital signs (HR, BP, RR, SpO2 within acceptable limits)
- Pain controlled by oral analgesia
- Nausea/vomiting minimal or well-controlled
- No unexpected bleeding from operative/procedure site
- Able to walk without dizziness (or has returned to pre-procedure mobility)
- Voiding urine (mandatory only in those at high risk for urinary retention; routine voiding requirement has been abandoned in low-risk patients)
- Received written discharge instructions with emergency contact information
- Responsible adult escort present to accompany the patient home
- Effects of sedation have resolved - patient must NOT drive or operate machinery for ≥24 hours
Special note: Reversal agents (flumazenil for midazolam; naloxone for opioids/pentazocine) should NOT be used as a substitute for adequate recovery time, as they may wear off before the sedative agent, causing re-sedation.
References: Sabiston Textbook of Surgery, 21e | Katzung's Basic & Clinical Pharmacology, 16e | Barash's Clinical Anesthesia, 9e | Miller's Anesthesia, 10e | Morgan & Mikhail's Clinical Anesthesiology, 7e | Tintinalli's Emergency Medicine, 9e